Meyers-Riggs, B. Alpha substituted tryptamines. countyourculture, countyourculture: rational exploration of the underground, 1 Mar 2012.
Glennon, RA; Young, R; Jacyno, JM. Indolealkylamine and phenalkylamine hallucinogens: Effect of α-methyl and N-methyl substituents on behavioral activity. Biochem. Pharmacol., 1 Apr 1983, 32 (7), 1267–1273. 591 kB. https://doi.org/10.1016/0006-2952(83)90281-2
Krebs, KM; Geyer, MA. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats. Psychopharmacology, 1 Dec 1993, 113 (2), 284–287. 472 kB. https://doi.org/10.1007/BF02245712
Glennon, RA; Gessner, PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. 731 kB. https://doi.org/10.1021/jm00190a014
Huang, X; Johnson, MP; Nichols, DE. Reduction in brain serotonin markers by α-ethyltryptamine (Monase). Eur. J. Pharmacol., 23 Jul 1991, 200 (1), 187–190. 420 kB. https://doi.org/10.1016/0014-2999(91)90686-K
Glennon, RA. MDMA-like stimulus effects of α-ethyltryptamine and the α-ethyl homolog of DOM. Pharmacol. Biochem. Behav., 1 Oct 1993, 46 (2), 459–462. 396 kB. https://doi.org/10.1016/0091-3057(93)90379-8
Kalir, A; Szara, S. Synthesis and pharmacological activity of alkylated tryptamines. J. Med. Chem., 1 May 1966, 9 (3), 341–344. 482 kB. https://doi.org/10.1021/jm00321a017 #4
Hong, S; Young, R; Glennon, RA. Discriminative stimulus properties of α-ethyltryptamine optical isomers. Pharmacol. Biochem. Behav., 1 Oct 2001, 70 (2–3), 311-316. 131 kB. https://doi.org/10.1016/S0091-3057(01)00605-0
Schulze-Alexandru, M; Kovar, K; Vedani, A. Quasi-atomistic receptor surrogates for the 5-HT2A receptor: A 3D-QSAR study on hallucinogenic substances. Quant. Struct.-Act. Relat., 1 Dec 1999, 18 (6), 548–560. 312 kB. https://doi.org/10.1002/(SICI)1521-3838(199912)18:6<548::AID-QSAR548>3.0.CO;2-B
Daldrup, T; Heller, C; Matthiesen, U; Honus, S; Bresges, A; Haarhoff, K. Etryptamin, eine neue designer-droge mit fataler Wirkung. Z. Rechtsmed., 1 Sep 1986, 97 (1), 61–68. 496 kB. https://doi.org/10.1007/BF00200960
Steiner, WG; Pscheidt, GR; Costa, E; Himwich, HE. α-Ethyltryptamine (etryptamine): An electroencephalographic, behavioral and neurochemical analysis. Psychopharmacology, 1 Sep 1963, 4 (5), 354–366. 780 kB. https://doi.org/10.1007/BF00405246
Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens. Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #57
Nichols, DE. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr. Transp. Signal, 1 Sep 2012, 1 (5), 559-579. 573 kB. https://doi.org/10.1002/wmts.42
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Shulgin, AT. Hallucinogens. In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., John Wiley & Sons, Inc., 1 Jan 1981; pp 1109–1137. 4.7 MB. #30
Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1 Jan 1976; Vol. 4, pp 59–146. 3.1 MB. #XXIV,XXVII
Hoffer, A; Osmond, H. The Hallucinogens, Academic Press, New York, . 3.9 MB. #a-Ethyltryptamine
Glennon, R; Bondareva, T; Young, R. α-Ethyltryptamine (α-ET) as a discriminative stimulus in rats. Pharmacol. Biochem. Behav., 1 Oct 2006, 85 (2), 448–453. 245 kB. https://doi.org/10.1016/j.pbb.2006.09.014 #α-ET
Barlow, RB; Khan, I. Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations. Br. J. Pharmacol., 1 Mar 1959, 14 (1), 99–107. 1.9 MB. https://doi.org/10.1111/j.1476-5381.1959.tb00934.x #18 other
Anon. DEA places α–ethyltryptamine into emergency schedule I. JCLIC, 1 Mar 1993, 3 (2), 4-4. 513 kB. #α–Ethyltryptamine
Brimblecombe, RW; Pinder, RM. Hallucinogenic agents, Wright-Scientechnica, Bristol, UK, 1 Jan 1975. 46.2 MB. #4.28